Država: Irska
Jezik: angleščina
Source: HPRA (Health Products Regulatory Authority)
Tafluprost; Timolol
PCO Manufacturing Ltd.
S01ED; S01ED51
Tafluprost; Timolol
15+5
Eye drops, solution in single-dose container
Beta blocking agents1); timolol, combinations
2021-06-18
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT TAPTIQOM 15 MICROGRAMS/ML + 5 MG/ML EYE DROPS, SOLUTION IN SINGLE-DOSE CONTAINER tafluprost/timolol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Taptiqom is and what it is used for 2. What you need to know before you use Taptiqom 3. How to use Taptiqom 4. Possible side effects 5. How to store Taptiqom 6. Contents of the pack and other information 1. WHAT TAPTIQOM IS AND WHAT IT IS USED FOR WHAT KIND OF MEDICINE IS IT AND HOW DOES IT WORK? Taptiqom eye drops contain tafluprost and timolol. Tafluprost belongs to a group of medicines called prostaglandin analogues and timolol belongs to a group of medicines called beta blockers. Tafluprost and timolol work together and lower the pressure in the eye. Taptiqom is used when the pressure in the eye is too high. WHAT IS YOUR MEDICINE FOR? Taptiqom is used to treat a type of glaucoma called open angle glaucoma and also a condition known as ocular hypertension in adults. Both of these conditions are linked with an increase in the pressure within your eye and eventually they may affect your eyesight. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE TAPTIQOM DO NOT USE TAPTIQOM: if you are allergic to tafluprost, timolol, beta blockers or any of the other ingredients of this medicine (listed in section 6.) if you have now or have had in the past respiratory problems such as asthma, severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing Preberite celoten dokument
Health Products Regulatory Authority 21 June 2021 CRN00CCSD Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml solution contains: tafluprost 15 micrograms and timolol (as maleate) 5 mg. One single-dose container (0.3 ml) of eye drops, solution, contains 4.5 micrograms of tafluprost and 1.5 mg of timolol. One drop (about 30 microl) contains about 0.45 micrograms of tafluprost and 0.15 mg of timolol. Excipient with known effect: phosphates. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Eye drops, solution in single-dose container (eye drops). A clear, colourless solution with a pH of 6.0-6.7 and an osmolality of 290-370 mOsm/kg. 4 CLINICAL PARTICULARS As per PA0879/003/001 5 PHARMACOLOGICAL PROPERTIES As per PA0879/003/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Glycerol Disodium phosphate dodecahydrate Disodium edetate Polysorbate 80 Hydrochloric acid and/or sodium hydroxide for pH adjustment Water for injections 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. After first opening a foil pouch: 28 days. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Store in a refrigerator (2°C - 8°C). Health Products Regulatory Authority 21 June 2021 CRN00CCSD Page 2 of 2 After opening the foil pouch: - Keep the single-dose containers in the original foil pouch in order to protect from light - Do not store above 25°C - Discard an opened single-dose container with any remaining solution immediately after use. 6.5 NATURE AND CONTENTS OF CONTAINER Low-density polyethylene (LDPE) single-dose containers packed in a foil pouch made of a paper-coated, aluminium-polyethylene laminate. Each single-dose container has a fill volume of 0.3 ml and there are 10 containers in each foil pouch. Pack of Preberite celoten dokument